Figure 5.
Melanoma-specific survival among patients with nodal metastases. Subgroup 1 comprised patients with a tumor-positive sentinel node; subgroup 2, the patients in subgroup 1 plus those in subgroup 4 with a nodal recurrence after a negative result on biopsy; subgroup 3, those with nodal recurrence during observation; and subgroup 4, those with nodal recurrence after a negative result on biopsy. Reprinted with permission from Morton et al.81